Freenome CEO Gabriel Otte received two very different term sheets when fundraising for his diagnostics startup earlier this year. Freenome is one of half a dozen companies in the red hot "liquid biopsy" space, which is aiming to develop a blood test to detect cancer at the earliest stages. One of the term sheets came from a traditional health and life...